An immunological memory in the brain

Tübingen (Germany), April 11th, 2018. Inflammatory reactions can change the brain’s immune cells in the long term – meaning that these cells have an ‘immunological memory’. This memory may influence the progression of neurological disorders that occur later in life, and is therefore a previously unknown factor that could influence the severity of these diseases. Scientists at the German Center for Neurodegenerative Diseases (DZNE), the Hertie Institute for Clinical Brain Research (HIH), and the University of Tübingen report on this in the journal “Nature”. Their study is the result of a collaborative effort also involving researchers from Göttingen, Bonn, and Freiburg.

Microglia are immune cells that only occur in the brain. They protect the brain by cleansing it of intruders and toxic substances. However, in certain situations they can also cause damage. Therefore, they have long been suspected of playing a central role in neurodegenerative diseases.

As microglia are very long-lived, the scientists were keen to find out whether environmental factors change these immune cells over time and what effect this can have on brain health. “Epidemiological studies have shown that infectious diseases and inflammation suffered during a lifetime can affect the severity of Alzheimer’s disease much later in life. We therefore asked ourselves whether an immunological memory in these long-lived microglia could be communicating this risk,” explains Dr. Jonas Neher, head of the current study and a scientist at the DZNE and the HIH.

Stimulated immune reaction

In order to address this question, Neher and colleagues triggered inflammation in mice, outside their brains; it was already known that such an inflammation can stimulate an immune reaction in the brain. However, it was not clear whether microglia might be able to remember a previous inflammation. As it turned out: Depending on how often the scientists repeated this process, they were able to induce two different states in the microglia: “training” and “tolerance”. The first inflammatory stimulus trained the microglia, causing them to react more strongly to the second. However, after a fourth stimulus, tolerance had occurred and the microglia barely responded.

Next, the researchers investigated how microglia training and tolerance affected the formation of amyloid plaques in the long term. Such “plaques” are characteristic toxic deposits that accumulate in the brains of patients with Alzheimer’s disease. In a mouse model of Alzheimer’s pathology, the scientists observed that trained microglia amplified the formation of plaques even months after their immunological memory had been triggered, thus causing the disease to become more severe. In contrast, tolerant microglia reduced plaque load. The scientists also noticed similar effects in a mouse model of stroke.

Changes in DNA

In order to understand these effects more precisely, Neher and coworkers investigated epigenetic changes in the microglia, i.e. chemical modifications to the DNA or its packaging proteins that cause certain genes to become more or less active. As epigenetic modifications are very stable, the researchers saw in them a possible cause for the long-term behavioral changes exhibited by the microglia. This hypothesis turned out to be correct: even many months after the initial immune stimulus, both the trained and the tolerant microglia showed specific epigenetic changes and corresponding differences in gene activation. This molecular reprogramming changed important functions in the microglia, such as their ability to remove amyloid plaques. And this affected Alzheimer’s pathology. 

Consequences for neurodegenerative diseases?

“It is possible that also in humans, inflammatory diseases that primarily develop outside the brain could trigger epigenetic reprogramming inside the brain,” says Neher. Both infections and diseases such as diabetes or arthritis are associated with inflammatory reactions and are known risk factors for Alzheimer’s disease. The brain’s immunological memory – epigenetically modified microglia – is one possible explanation for this effect. Therefore, Neher and colleagues are now investigating the conditions under which microglia undergo epigenetic changes in humans and looking at the therapeutic possibilities that may arise from this.


This study was supported by a PhD fellowship of the Studienstiftung des Deutschen Volkes, a Roman Herzog Fellowship of the Hertie Foundation, and grants from the network ‘Neuroinflammation in Neurodegeneration’, the Sobek-Stiftung, the DFG, the European Research Council, the Fortüne Program, the Fritz Thyssen Foundation and the Paul G. Allen Family Foundation.

This image shows such immune cells (in black) clustered around plaques (in red), which are insoluble protein deposits characteristic of Alzheimer’s disease.
Portait Jonas Neher

Researchers from Tübingen (Germany) have found that the immune cells of the brain remember previous inflammations. They report on this in the journal Nature. This image shows such immune cells (in black) clustered around plaques (in red), which are insoluble protein deposits characteristic of Alzheimer’s disease. Source: DZNE & HIH / Neher

Head of the current study: Dr. Jonas Neher, scientist at the Hertie Institute for Clinical Brain Research and the German Center for Neurodegenerative Diseases. Source: HIH / Akshay Markanday


Dr. Marcus Neitzert
Science Editor
 +49 228 43302-267

Original publication

Innate immune memory in the brain shapes neurological disease hallmarks
Wendeln, Degenhardt et al. Nature (2018), advanced online publication on April 11th 2018
DOI: 10.1038/s41586-018-0023-4


Thursdays 1:30-4:30 pm

Patients +49 800-7799001

(free of charge)

Professionals +49 180-779900

(9 Cent/Min. German landline, mobile and out of Germany possibly more expensive)